Trial Profile
A Prospective Multicenter Phase III Clinical Evaluation of the Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress Echocardiography With Dobutamine for the Diagnosis of Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2021
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use; Registrational
- Sponsors Bracco Diagnostics
- 08 Aug 2018 Status changed from active, no longer recruiting to completed.
- 07 Aug 2018 This trial has been completed in UK-MHRA (end date: 2018-02-25)
- 12 Apr 2018 This trial has been completed in Belgium (end date: 2018-02-25)